MARLISSA
MARLISSA (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg)
Approved
Approval ID
9379d99e-c416-4dab-a817-1c110e0d4b93
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 22, 2022
Manufacturers
FDA
Glenmark Pharmaceuticals Inc., USA
DUNS: 130597813
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Levonorgestrel and Ethinyl Estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code68462-388
Application NumberANDA091452
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levonorgestrel and Ethinyl Estradiol
Product Specifications
Effective DateJune 22, 2022
FDA Product Classification